Clinical characteristics and predictive value of lower CD4⁺T cell level in patients with moderate and severe COVID-19: a multicenter retrospective study.

ABSTRACT:

Background

In December 2019, coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, Hubei, China. Moreover, it has become a global pandemic. This is of great value in describing the clinical symptoms of COVID-19 patients in detail and looking for markers which are significant to predict the prognosis of COVID-19 patients.

Methods

In this multicenter, retrospective study, 476 patients with COVID-19 were enrolled from a consecutive series. After screening, a total of 395 patients were included in this study. All-cause death was the primary endpoint. All patients were followed up from admission till discharge or death.

Results

The main symptoms observed in the study included fever on admission, cough,

SUBMITTER: Wen XS 

PROVIDER: S-EPMC7803000 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature